Airworthiness Directives: Gulfstream Aerospace LP Airplanes (Type Certificate Previously Held by Israel Aircraft Industries, Ltd.)

FAA-2026-4654-0001NPRM

Comments

Last activity Jul 24, 2026

Deadline

Closed on Jul 25, 2026

Closed Jul 25, 2026

Net supporti

+67%

+67% excluding campaigns

Document

Details

The document's own metadata, straight from the source system.

Title: Airworthiness Directives: Gulfstream Aerospace LP Airplanes (Type Certificate Previously Held by Israel Aircraft Industries, Ltd.)

Posted: Jun 9, 2026
Comment period: Jun 9, 2026 – Jul 25, 2026
Agency: Federal Aviation Administration (FAA)
FR Doc: 2026-11512
CFR: 14 CFR Part 39
Topics: Aviation & Air Safety

View on regulations.gov ↗

Analysis

Overview

What the public is saying — stance, who's commenting, and the issues they raise.

Include campaigns

Stance breakdown

+67%

Net support

Support2Other1

Aggregates include form-letter campaigns. Excluding them, net support is +67% across organic comments.

Who commented

Breakdown by commenter type.

Individual

Comments over time

Weekly arrivals, stacked by stance.

Posted Jun 9, 2026Deadline Jul 25, 2026

Jun 8Jul 20

Support2Oppose0Other1

Support × commenter type

How each type splits across stance.

Support

Oppose

Other

Individual

67%

33%

Issues raised

The docket's canonical issues. Select one to browse its comments.

Mandatory gmp standards for peptides1

→

Comments

Explorer

Every mirrored comment — filter by stance, campaign, or issue.

Filter:

alfredo irazabal
Jun 9, 2026
SupportIndividual📎 Attachment
Alfredo Arizabal, an independent dentist, supports the inclusion of several peptides on the 503A Bulk Drug Substances List but argues that the FDA must mandate strict Good Manufacturing Practice (GMP) standards for their production. He also requests clarification on the "wound healing" indication for BPC-157 to ensure it covers internal tissue repair and asks for the expansion of MOTs-C's indications to include Type 2 Diabetes.
Read comment →